The new evidence suggests that in addition to the known ACE2 receptor, TLR-4, KIM-1/TIM-1, and CD147 play crucial roles in the pathogenesis of COVID-19 and specifically in the mediation of viral entry into kidney cells and the onset of kidney cell damage. The gene discussed is HAVCR1; the disease is COVID-19.